IBDEI12R ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18267,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,18268,0)
 ;;=E11.51^^79^874^67
 ;;^UTILITY(U,$J,358.3,18268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18268,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,18268,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,18268,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,18269,0)
 ;;=E11.621^^79^874^68
 ;;^UTILITY(U,$J,358.3,18269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18269,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18269,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,18269,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,18270,0)
 ;;=E11.65^^79^874^69
 ;;^UTILITY(U,$J,358.3,18270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18270,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,18270,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,18270,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,18271,0)
 ;;=E11.649^^79^874^70
 ;;^UTILITY(U,$J,358.3,18271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18271,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,18271,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,18271,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,18272,0)
 ;;=E11.618^^79^874^64
 ;;^UTILITY(U,$J,358.3,18272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18272,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,18272,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,18272,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,18273,0)
 ;;=E11.638^^79^874^71
 ;;^UTILITY(U,$J,358.3,18273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18273,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,18273,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,18273,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,18274,0)
 ;;=E11.628^^79^874^73
 ;;^UTILITY(U,$J,358.3,18274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18274,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,18274,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,18274,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,18275,0)
 ;;=E11.622^^79^874^74
 ;;^UTILITY(U,$J,358.3,18275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18275,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,18275,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,18275,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,18276,0)
 ;;=E11.69^^79^874^63
 ;;^UTILITY(U,$J,358.3,18276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18276,1,3,0)
 ;;=3^Diabetes Type 2 w/ Complications NEC
 ;;^UTILITY(U,$J,358.3,18276,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,18276,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,18277,0)
 ;;=E11.630^^79^874^72
 ;;^UTILITY(U,$J,358.3,18277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18277,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,18277,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,18277,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,18278,0)
 ;;=I83.223^^79^874^147
 ;;^UTILITY(U,$J,358.3,18278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18278,1,3,0)
 ;;=3^Varicose Veins of Left Lower Extrem w/ Ankle Ulcer/Inflammation
 ;;^UTILITY(U,$J,358.3,18278,1,4,0)
 ;;=4^I83.223
 ;;^UTILITY(U,$J,358.3,18278,2)
 ;;=^5008006
 ;;^UTILITY(U,$J,358.3,18279,0)
 ;;=I83.222^^79^874^148
 ;;^UTILITY(U,$J,358.3,18279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18279,1,3,0)
 ;;=3^Varicose Veins of Left Lower Extrem w/ Calf Ulcer/Inflammation
 ;;^UTILITY(U,$J,358.3,18279,1,4,0)
 ;;=4^I83.222
 ;;^UTILITY(U,$J,358.3,18279,2)
 ;;=^5008005
 ;;^UTILITY(U,$J,358.3,18280,0)
 ;;=I83.224^^79^874^149
 ;;^UTILITY(U,$J,358.3,18280,1,0)
 ;;=^358.31IA^4^2
